These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11145960)

  • 1. A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells.
    Diana F; Sgarra R; Manfioletti G; Rustighi A; Poletto D; Sciortino MT; Mastino A; Giancotti V
    J Biol Chem; 2001 Apr; 276(14):11354-61. PubMed ID: 11145960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group I/Y: multifunctional chromosomal proteins causally involved in tumor progression and malignant transformation (review).
    Wisniewski JR; Schwanbeck R
    Int J Mol Med; 2000 Oct; 6(4):409-19. PubMed ID: 10998430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry.
    Sgarra R; Diana F; Bellarosa C; Dekleva V; Rustighi A; Toller M; Manfioletti G; Giancotti V
    Biochemistry; 2003 Apr; 42(12):3575-85. PubMed ID: 12653562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collective mass spectrometry approaches reveal broad and combinatorial modification of high mobility group protein A1a.
    Young NL; Plazas-Mayorca MD; DiMaggio PA; Flaniken IZ; Beltran AJ; Mishra N; LeRoy G; Floudas CA; Garcia BA
    J Am Soc Mass Spectrom; 2010 Jun; 21(6):960-70. PubMed ID: 20202861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions.
    Banks GC; Li Y; Reeves R
    Biochemistry; 2000 Jul; 39(28):8333-46. PubMed ID: 10889043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
    Edberg DD; Adkins JN; Springer DL; Reeves R
    J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein.
    Zou Y; Wang Y
    Biochemistry; 2005 Apr; 44(16):6293-301. PubMed ID: 15835918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
    Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
    Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of HMGA1a protein methylation is a distinctive characteristic of leukaemic cells induced to undergo apoptosis.
    Sgarra R; Diana F; Rustighi A; Manfioletti G; Giancotti V
    Cell Death Differ; 2003 Mar; 10(3):386-9. PubMed ID: 12700639
    [No Abstract]   [Full Text] [Related]  

  • 10. The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6.
    Sgarra R; Lee J; Tessari MA; Altamura S; Spolaore B; Giancotti V; Bedford MT; Manfioletti G
    J Biol Chem; 2006 Feb; 281(7):3764-72. PubMed ID: 16293633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation orchestrates the structural ensemble of the intrinsically disordered protein HMGA1a and modulates its DNA binding to the NFκB promoter.
    Kohl B; Zhong X; Herrmann C; Stoll R
    Nucleic Acids Res; 2019 Dec; 47(22):11906-11920. PubMed ID: 31340016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic interaction of HMGA1a proteins with chromatin.
    Harrer M; Lührs H; Bustin M; Scheer U; Hock R
    J Cell Sci; 2004 Jul; 117(Pt 16):3459-71. PubMed ID: 15213251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation.
    Piekielko A; Drung A; Rogalla P; Schwanbeck R; Heyduk T; Gerharz M; Bullerdiek J; Wiśniewski JR
    J Biol Chem; 2001 Jan; 276(3):1984-92. PubMed ID: 11034995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdc2 and mitogen-activated protein kinases modulate DNA binding properties of the putative transcriptional regulator Chironomus high mobility group protein I.
    Schwanbeck R; Wiśniewski JR
    J Biol Chem; 1997 Oct; 272(43):27476-83. PubMed ID: 9341202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
    Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
    J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells.
    Jiang X; Wang Y
    Biochemistry; 2006 Jun; 45(23):7194-201. PubMed ID: 16752910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors.
    Tallini G; Dal Cin P
    Adv Anat Pathol; 1999 Sep; 6(5):237-46. PubMed ID: 10472377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and assays for high mobility group HMG-I(Y) protein function.
    Reeves R; Nissen MS
    Methods Enzymol; 1999; 304():155-88. PubMed ID: 10372360
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B; Dubrez L; Allouche M; Solary E
    Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.